Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Antman

Showing results (11-20 of 183) with videos related to

Pageof 19
Sort By:
Circulation|September 1, 1996
Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trialE M Antman
Circulation|May 23, 2001
The search for replacements for unfractionated heparinE M Antman
Circulation|October 1, 1994
Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A TrialE M Antman
Journal of Cardiovascular Electrophysiology|October 1, 1995
Atrial fibrillation and flutter: maintaining stability of sinus rhythm versus ventricular rate controlE M Antman
European Heart Journal|July 1, 1996
Trials and tribulations of thrombin inhibitionE M Antman, E Braunwald
Hospital Practice (Office Ed.)|July 15, 1990
Acute MI management in the 1990sE M Antman, E Braunwald
Annals of Internal Medicine|April 1, 1997
Evidence-based coronary careE Braunwald, E M Antman
Archivos De Cardiologia De Mexico|January 25, 2002
[Magnesium in the treatment of acute myocardial infarction. Review and controversies]U Juárez, E M Antman
American Heart Journal|November 30, 1999
Newer antithrombin agents in acute coronary syndromesE M Antman, M Cohen
Circulation|August 26, 1998
Low-molecular-weight heparins: an intriguing new twist with profound implicationsE M Antman, R Handin
Pageof 19

Showing results (11-20 of 183) with videos related to

Sort By:
Pageof 19
Circulation|September 1, 1996
Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trialE M Antman
Circulation|May 23, 2001
The search for replacements for unfractionated heparinE M Antman
Circulation|October 1, 1994
Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A TrialE M Antman
Journal of Cardiovascular Electrophysiology|October 1, 1995
Atrial fibrillation and flutter: maintaining stability of sinus rhythm versus ventricular rate controlE M Antman
European Heart Journal|July 1, 1996
Trials and tribulations of thrombin inhibitionE M Antman, E Braunwald
Hospital Practice (Office Ed.)|July 15, 1990
Acute MI management in the 1990sE M Antman, E Braunwald
Annals of Internal Medicine|April 1, 1997
Evidence-based coronary careE Braunwald, E M Antman
Archivos De Cardiologia De Mexico|January 25, 2002
[Magnesium in the treatment of acute myocardial infarction. Review and controversies]U Juárez, E M Antman
American Heart Journal|November 30, 1999
Newer antithrombin agents in acute coronary syndromesE M Antman, M Cohen
Circulation|August 26, 1998
Low-molecular-weight heparins: an intriguing new twist with profound implicationsE M Antman, R Handin
Pageof 19